---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-013774"
form_type: "8-K"
ticker: "ANNX"
cik: "0001528115"
company_name: "Annexon, Inc."
filed_at: "2022-01-20T23:59:59+00:00"
generated_at: "2026-06-27T16:48:25.859237+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Annexon appoints Dr. Bettina Cockroft to board of directors

## Summary
- Dr. Cockroft is SVP and CMO of Sangamo Therapeutics, effective immediately.
- Appointed as Class III director with term expiring at 2023 annual meeting.
- Receives $35,000 annual retainer, initial option for 20,000 shares, and annual grant for 10,000 shares.
- She brings nearly 20 years of clinical development experience in neurodegenerative and movement disorders.
- Annexon highlights her expertise as it advances complement-mediated therapies in GBS and Huntington's disease.

## SEC filing metadata
- accession: 0001193125-22-013774
- form_type: 8-K
- ticker: ANNX
- cik: 0001528115
- company_name: Annexon, Inc.
- filed_at: 2022-01-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1528115/000119312522013774/0001193125-22-013774-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1528115/000119312522013774/d477760d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-013774
- JSON: https://secwatch.observer/filing/0001193125-22-013774.json
- Plain text: https://secwatch.observer/filing/0001193125-22-013774.txt

## Key facts
- Executive change
  Bettina M. Cockroft was appointed as Director at Annexon, Inc..
  - Action: appointed
  - Role: Director
  source text: On January 19, 2022, the Board of Directors (the “Board”) of Annexon, Inc. (the “Company”) appointed Bettina M. Cockroft, M.D., to the Board, effectively immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1528115/000119312522013774/0001193125-22-013774-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.